AHA today urged the Drug Enforcement Administration to include drug shortages as a factor when setting and adjusting aggregate and individual manufacturers’ production quotas for controlled substances. Commenting on the agency’s proposed rule on controlled substances quotas, AHA also recommended that DEA routinely consult with the Food and Drug Administration’s drug shortage staff when establishing and adjusting quotas. “As the DEA is well aware, hospitals and health systems continue to experience critical shortages of a number of injectable opioid medications, such as morphine, hydromorphone and fentanyl, due to both a slowdown in production and a component problem at a major manufacturing facility,” AHA wrote. “These intravenous opioids are widely used and essential to appropriate patient care in hospitals and in other practice settings for the treatment of acute and chronic pain, and for sedation purposes.” AHA also joined with the American Society of Health-System Pharmacists, America’s Health Insurance Plans, American Society of Clinical Oncology, American Society of Anesthesiologists, and Institute for Safe Medication Practices in a letter to DEA requesting similar changes to the proposed rule.

Related News Articles

Headline
The National Academies of Sciences Engineering, and Medicine yesterday released recommendations for improving outcomes and metrics associated with four grant…
Headline
The Centers for Medicare & Medicaid Services recently announced a six-month delay in implementation of its Innovation Center Maternal Opioid Misuse (MOM)…
Headline
Mallinckrodt Pharmaceuticals today announced an agreement in principle on a settlement to resolve all opioid-related claims against the company in…
Headline
Public and private entities can apply for $1 million grants for a three-year period to enhance or expand opioid and other substance use disorder services in…
Headline
Rep. Vicky Hartzler, R-Mo., House Energy and Commerce Committee Ranking Member Greg Walden, R-Ore., and other Republicans on the committee last week asked the…
Headline
The House Energy and Commerce Subcommittee on Oversight and Investigations today held a hearing to highlight how federal funds have helped states combat…